Covidh Technologies Intrinsic Value

Covidh Technologies (COVIDH) median intrinsic value is ₹31.18 from 3 valuation models (range ₹21–₹42), vs current price ₹103.94 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Read Covidh Technologies dividend payments for the complete payout history and dividend yield track record.

Current Stock Price
₹103.94
Primary Intrinsic Value
₹20.79
Market Cap
₹114.3 Cr
-70.0% Downside
Median Value
₹31.18
Value Range
₹21 - ₹42
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

COVIDH Valuation Methods Summary — DCF, Graham Number & P/E

Covidh Technologies intrinsic value across 3 models vs current price ₹103.94 — upside/downside and value range per method. For current market price and key ratios, visit COVIDH screener.

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹20.79 ₹18.71 - ₹22.87 -80.0% Book Value/Share: ₹0.91, P/B: 1.0x
Revenue Multiple Method revenue ₹31.18 ₹28.06 - ₹34.30 -70.0% Revenue/Share: ₹14.55, P/S: 0.8x
Simple DCF (5Y) dcf ₹41.58 ₹33.26 - ₹49.90 -60.0% CF Growth: 5.0%, Discount: 15%
Method Types: Earnings Asset DCF Growth Dividend Conservative

COVIDH Intrinsic Value vs Market Price — All Valuation Models

Covidh Technologies fair value range ₹21–₹42 vs current market price ₹103.94 across 3 valuation models. Analyse Covidh Technologies shareholding analysis to track promoter, FII and institutional holdings.

COVIDH Intrinsic Value Analysis — Undervalued or Overvalued?

Covidh Technologies median intrinsic value ₹31.18, current price ₹103.94 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.

What is the intrinsic value of COVIDH?

Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Covidh Technologies (COVIDH) is ₹31.18 (median value). With the current market price of ₹103.94, this represents a -70.0% variance from our estimated fair value.

The valuation range spans from ₹20.79 to ₹41.58, indicating ₹20.79 - ₹41.58.

Is COVIDH undervalued or overvalued?

Based on our multi-method analysis, Covidh Technologies (COVIDH) appears to be trading above calculated value by approximately 70.0%.

COVIDH Financial Health — Key Ratios vs Industry Benchmarks

Covidh Technologies financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 2.12 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Operating Margin 6.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 0.89x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

COVIDH Cash Flow Quality — Operating & Free Cash Flow

Covidh Technologies operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2019 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2018 ₹-1 Cr ₹-1 Cr Negative Cash Flow 3/10
March 2016 ₹1 Cr ₹1 Cr Positive Free Cash Flow 8/10
March 2015 ₹1 Cr ₹1 Cr Positive Free Cash Flow 7/10